Myelodysplastic syndromes (MDS) in Central Africans.

Myelodysplastic syndromes (MDS) in Central Africans.
复制标题

中非人的骨髓增生异常综合征(MDS)。

DOI:
--
复制
发表时间:
1994
期刊:
Tropical and geographical medicine
影响因子:
--
通讯作者:
B. Paul
B. Paul
中科院分区:
--
文献类型:
--
作者:
JM Mukiibi;B. Paul

文献摘要

被引文献

相似文献

报道了津巴布韦大学哈拉雷血液学系的42名患者,他们在6年的时间里接受了法美英(FAB)骨髓增生异常综合征(MDS)的诊断标准。年龄范围29~75岁,平均+/-SD为57.8+/-11.2岁。难治性贫血(RA)占33.3%,环状铁粒母细胞(RARS)占16.7%,难治性贫血伴原始细胞增多(RAEB)占21.4%,转化中原始细胞增多的难治性贫血(RAEB-T)占16.7%,慢性粒单核细胞白血病(CMML)占11.9%。90.5%的人是原发疾病,9.5%的人以前接触过骨髓毒性药物会导致继发性MDS。这项研究表明,由于疟疾猖獗、营养不良和一系列营养不足,MDS作为非洲人口贫血的原因通常隐藏在大量众所周知的贫血中。因此,有必要提高我们的临床医生对这些疾病的存在的诊断意识。
Forty two patients who were seen and satisfied the French-American-British (FAB) diagnostic criteria for myelodysplastic syndromes (MDS) over a 6-year period at the University of Zimbabwe's Department of Haematology, Harare, are presented. Their overall ages ranged from 29 to 75 years with a mean +/- SD of 57.8 +/- 11.2 years. Males outnumbered females with a male to female ratio of 1.2:1. Refractory anaemia (RA) occurred in 33.3%; refractory anaemia with ringed sideroblasts (RARS) in 16.7%; refractory anaemia with excess blasts (RAEB) in 21.4%; refractory anaemia with excess blasts in transformation (RAEB-T) in 16.7% and chronic myelomonocytic leukaemia (CMML) in 11.9% of the patients. In 90.5% the disease was primary and in 9.5% prior exposure to myelotoxic agents resulted in secondary MDS. The study reveals that MDS as a cause of anaemia in the African population is usually hidden in the big number of well known anaemias due to rampant malaria, malnutrition and a host of nutritional deficiencies. There is therefore the need to increase diagnostic awareness among our clinicians about the existence of these disorders.